Alerus Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Buy |
48,583
+46,853
| +2,708% | +$1.25M | 0.07% | 123 |
|
|
2025
Q4 | $43.1K | Hold |
1,730
| – | – | ﹤0.01% | 250 |
|
|
2025
Q3 | $44.1K | Sell |
1,730
-1,193
| -41% | -$29.4K | ﹤0.01% | 269 |
|
|
2025
Q2 | $70.9K | Buy |
+2,923
| New | +$68.2K | 0.01% | 219 |
|
|
2023
Q4 | – | Sell |
-7,935
| Closed | -$263K | – | 160 |
|
|
2023
Q3 | $263K | Sell |
7,935
-293
| -4% | -$10.4K | 0.02% | 136 |
|
|
2023
Q2 | $302K | Sell |
8,228
-7,505
| -48% | -$292K | 0.03% | 139 |
|
|
2023
Q1 | $642K | Sell |
15,733
-123,568
| -89% | -$5.34M | 0.06% | 115 |
|
|
2022
Q4 | $7.14M | Buy |
139,301
+113,519
| +440% | +$5.44M | 0.65% | 37 |
|
|
2022
Q3 | $1.13M | Sell |
25,782
-89,277
| -78% | -$4.34M | 0.11% | 105 |
|
|
2022
Q2 | $6.03M | Buy |
115,059
+2,854
| +3% | +$145K | 0.56% | 41 |
|
|
2022
Q1 | $5.81M | Buy |
112,205
+11,832
| +12% | +$614K | 0.5% | 51 |
|
|
2021
Q4 | $5.93M | Sell |
100,373
-20,391
| -17% | -$1.01M | 0.48% | 46 |
|
|
2021
Q3 | $5.19M | Sell |
120,764
-6,611
| -5% | -$293K | 0.47% | 47 |
|
|
2021
Q2 | $4.99M | Sell |
127,375
-10,879
| -8% | -$423K | 0.5% | 46 |
|
|
2021
Q1 | $5.01M | Sell |
138,254
-423
| -0.3% | -$15K | 0.53% | 48 |
|
|
2020
Q4 | $5.11M | Sell |
138,677
-38,571
| -22% | -$1.41M | 0.52% | 45 |
|
|
2020
Q3 | $6.17M | Buy |
177,248
+29,590
| +20% | +$1.04M | 0.69% | 32 |
|
|
2020
Q2 | $4.58M | Sell |
147,658
-10,162
| -6% | -$345K | 0.54% | 47 |
|
|
2020
Q1 | $4.89M | Sell |
157,820
-47,313
| -23% | -$1.61M | 0.68% | 36 |
|
|
2019
Q4 | $7.63M | Sell |
205,133
-29,742
| -13% | -$1.06M | 0.87% | 27 |
|
|
2019
Q3 | $8.01M | Buy |
234,875
+3,650
| +2% | +$133K | 1.04% | 20 |
|
|
2019
Q2 | $9.5M | Sell |
231,225
-17,397
| -7% | -$691K | 1.28% | 16 |
|
|
2019
Q1 | $10M | Buy |
248,622
+27,811
| +13% | +$1.11M | 1.4% | 15 |
|
|
2018
Q4 | $9.14M | Sell |
220,811
-864
| -0.4% | -$35.9K | 1.4% | 15 |
|
|
2018
Q3 | $9.27M | Sell |
221,675
-5,867
| -3% | -$226K | 1.27% | 17 |
|
|
2018
Q2 | $7.83M | Sell |
227,542
-1,563
| -0.7% | -$53.4K | 1.11% | 19 |
|
|
2018
Q1 | $7.71M | Buy |
229,105
+23,646
| +12% | +$813K | 1.11% | 20 |
|
|
2017
Q4 | $7.06M | Sell |
205,459
-3,529
| -2% | -$120K | 1% | 28 |
|
|
2017
Q3 | $7.08M | Buy |
208,988
+3,262
| +2% | +$105K | 1.03% | 29 |
|
|
2017
Q2 | $6.56M | Buy |
205,726
+15,094
| +8% | +$476K | 0.97% | 28 |
|
|
2017
Q1 | $6.19M | Buy |
190,632
+5,413
| +3% | +$171K | 0.95% | 32 |
|
|
2016
Q4 | $5.71M | Buy |
185,219
+863
| +0.5% | +$26.3K | 0.92% | 31 |
|
|
2016
Q3 | $5.92M | Buy |
184,356
+816
| +0.4% | +$27.3K | 0.96% | 32 |
|
|
2016
Q2 | $6.13M | Buy |
+183,540
| New | +$5.86M | 1.03% | 29 |
|
Other funds holding PFE
VCM
VPM
Alerus Financial's PFE Position: Q1 2026 in Review
Alerus Financial increased its Pfizer (PFE) stake by 2,708% in Q1 2026, buying an estimated $1.25M and bringing the position to 48,583 shares worth $1.36M. The position accounts for 0.07% of the portfolio, ranked #123.
Alerus Financial first reported a position in PFE in Q2 2016 and has held it in 34 quarters since. The position peaked at $10M in Q1 2019. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Alerus Financial held 48,583 shares of Pfizer worth $1.36M as of Q1 2026.
- Alerus Financial bought 46,853 Pfizer shares in Q1 2026, an estimated $1.25M.
- Pfizer made up 0.07% of Alerus Financial's portfolio in Q1 2026, its #123 holding.
- Alerus Financial first reported a position in Pfizer in Q2 2016 and has held it in 34 quarters since.
- Alerus Financial's Pfizer position peaked at $10M in Q1 2019.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.